Indefinite Delivery Contract 75F40123D00031
- Not listed
- This indefinite delivery contract (IDC) awarded by the U.S. Army Medical Command (MEDCOM) to Metabolon, Inc., a self-certified small disadvantaged business, provides specialized metabolomics analysis services to support MEDCOM's research initiatives in areas such as veteran health, precision medicine, and military medicine. The contract ceiling value is $3,170,397 and has an ultimate completion date of April 30, 2025. Under this IDC, Metabolon has been awarded multiple delivery orders to provide...
- The National Institutes of Health (NIH) has awarded a $250,000 Indefinite Delivery Contract (IDC) to Metabolon, Inc., a small disadvantaged business, to provide specialized metabolomics analysis services in support of a clinical research study examining the associations between diet, gut microbiome, and metabolite changes. This sole-source contract enables NIH's Clinical Center to efficiently procure Metabolon's proprietary testing capabilities, including analysis of bile acids, short chain...
- The key products and services being delivered under this Indefinite Delivery Contract (IDC) awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) are proteomics analysis services on human plasma and serum samples. The prime contractor, Somalogic Operating Co., Inc. (doing business as CM Life Sciences II Inc.), is a commercial-stage proteomics company that provides its proprietary SomaScan platform to measure thousands of proteins in small biospecimens....
- This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 4 (VISN 4) to Metabolon, Inc., a self-certified small disadvantaged business, to provide metabolic analysis services. The $33 million IDC covers task orders for analyzing EDTA plasma samples to support the VA's Million Veteran Program, which aims to advance research on veteran health issues. Under this IDC and related delivery orders, Metabolon utilizes its...
- The U.S. Army Medical Command awarded a single-award Indefinite Delivery Contract valued at $4.09M to Metabolon, Inc. for metabolomic analysis services of biological samples including urine, blood, fecal, saliva, and tissue. The contract, awarded July 15, 2025, with an ultimate completion date of July 15, 2030, establishes a vehicle through which the Department of Defense can efficiently procure Metabolon's specialized metabolomics expertise via task orders. Metabolon, a self-certified small...
- This Indefinite Delivery Contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Circana, LLC (doing business as Infoscan), a for-profit data and analytics firm. The single-award $20,001,000.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract runs from April 2, 2024 through April 1, 2029 and serves as a comprehensive vehicle for the FDA and potentially other federal partners to access Circana's consumer insights, data, and analytics services through...
- This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a prominent for-profit organization specializing in healthcare data, analytics, and clinical research services. The contract has a ceiling value of $16,803,000.00 and a period of performance from August 20, 2025, to August 21, 2027. The purpose of this IDC is to provide the FDA's Center for Drug Evaluation and Research with comprehensive access to outpatient...
- This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Mpza LLC, a minority and women-owned small business. The contract has a ceiling value of $40,000,000 and a period of performance through May 2028. The primary purpose of this IDC is to provide data management program support services for the FDA Adverse Event Reporting System (FAERS). This includes processing a backlog of adverse event reports, as well as ongoing data...
- The Department of Health and Human Services Food and Drug Administration awarded an Indefinite Delivery Contract with a potential value of $25 million to Midnight Sun Technologies LLC. The contract is a single award, 8(a) sole source set aside for scientific support services to be performed across multiple locations including Silver Spring, MD, Vienna, VA, and Calverton, MD. The contract aims to procure subject matter expertise through various labor categories such as Scientist III, Researcher...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Defense Medical Command (MEDCOM) to Metabolic Solutions, LLC, a for-profit limited liability company based in Nashua, New Hampshire. The single-award IDC has a ceiling value of $2,183,256.00 and a period of performance from July 16, 2024 to July 15, 2029. Under this IDC, Metabolic Solutions provides MEDCOM with analytical services, including stable isotope analysis of human biological samples such as urine, blood,...
- 75F40123D00031Indefinite Delivery Contract
- 1Federal Contract Awards
This is a single-award Indefinite Delivery Contract (IDC) awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Metabolon, Inc., a small disadvantaged business. The contract has a ceiling value of $296,000.00 and a period of performance through August 1, 2030. The purpose of this IDC is to provide the FDA with indefinite delivery/indefinite quantity (IDIQ) services for metabolomic analysis of biological samples. Metabolon, as the prime contractor, will utilize its proprietary analytical platforms and expertise in metabolomics to identify and quantify metabolites from samples such as blood, urine, tissue, and stool. These metabolomics services are intended to support the FDA's regulatory science initiatives, which may include research into disease mechanisms, drug safety evaluation, and other areas. The contract allows the FDA to efficiently procure Metabolon's specialized services through firm fixed price task orders over the multi-year period to meet the agency's ongoing research requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | ($148k) | 8/21/24 | |
| P00002 | Other Administrative Action | $0 | 8/15/24 | |
| P00001 | Other Administrative Action | $0 | 8/14/24 | |
| Not listed | Not listed | $148.0k | 9/7/23 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 75F40123D00031-75F40124F19001 | Metabolon, Inc. | $151.7k | 8/22/24 | 9/14/25 | 8/22/24 |